Stay updated on ABI-H0731 in Chronic Hepatitis B: Clinical Trial
Sign up to get notified when there's something new on the ABI-H0731 in Chronic Hepatitis B: Clinical Trial page.

Latest updates to the ABI-H0731 in Chronic Hepatitis B: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical trial record for ABI-H0731 in patients with chronic hepatitis B is now displayed, including its study design, treatment arms, eligibility criteria, locations, and outcome measures.SummaryDifference58%

- Check18 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide banner announces NIH's transition messaging and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study record page displays a 403 Forbidden message with a Home link instead of study details.SummaryDifference0.5%

Stay in the know with updates to ABI-H0731 in Chronic Hepatitis B: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABI-H0731 in Chronic Hepatitis B: Clinical Trial page.